MinichMacGregor Wealth Management LLC Sells 2,128 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

MinichMacGregor Wealth Management LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 83.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 420 shares of the healthcare conglomerate's stock after selling 2,128 shares during the period. MinichMacGregor Wealth Management LLC's holdings in UnitedHealth Group were worth $221,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. International Assets Investment Management LLC raised its stake in shares of UnitedHealth Group by 53,573.1% in the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate's stock worth $1,238,515,000 after buying an additional 2,348,107 shares during the period. Jennison Associates LLC boosted its position in shares of UnitedHealth Group by 49.3% in the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate's stock worth $1,904,670,000 after purchasing an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. raised its position in shares of UnitedHealth Group by 75.0% during the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate's stock valued at $1,014,002,000 after purchasing an additional 862,024 shares during the period. California Public Employees Retirement System boosted its holdings in UnitedHealth Group by 35.9% in the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate's stock worth $1,627,311,000 after buying an additional 815,822 shares during the period. Finally, Canoe Financial LP raised its holdings in UnitedHealth Group by 459.9% during the fourth quarter. Canoe Financial LP now owns 948,527 shares of the healthcare conglomerate's stock valued at $499,371,000 after acquiring an additional 779,107 shares during the period. Institutional investors own 87.86% of the company's stock.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the firm's stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm's stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Trading Up 0.4 %

UNH traded up $2.14 on Tuesday, reaching $513.88. 2,825,465 shares of the company traded hands, compared to its average volume of 4,289,188. The company has a market cap of $472.97 billion, a P/E ratio of 31.41, a price-to-earnings-growth ratio of 1.49 and a beta of 0.55. The firm has a fifty day simple moving average of $482.88 and a two-hundred day simple moving average of $511.48. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts' consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group's revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group's dividend payout ratio (DPR) is 45.97%.

Analysts Set New Price Targets

Several research analysts have weighed in on UNH shares. Bank of America restated a "buy" rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Truist Financial reissued a "buy" rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Piper Sandler boosted their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 17th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating on the stock in a research note on Monday, April 8th. Finally, Erste Group Bank restated a "hold" rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Three equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.